OBJECTIVE
To investigate the inhibition of sanguinarine on S180 sarcoma in mice and the effect of angiogenesis.
METHODS
S180 subcutaneous implanted tumor model mice were randomly divided into six groups: control group, cyclophosphamide (CTX) group, sanguinarine (10, 20 and 40 mg/kg) groups and